Nusano is committed to bringing stability to radiopharmaceutical supply chains so drugmakers, researchers and clinicians can serve patients and transform cancer care.

In 2025, Nusano will launch two breakthrough technologies poised to transform radioisotope supply availability: a proprietary separation process for high-volume non-carrier-added lutetium-177 (n.c.a. Lu-177) production, and a first-of-its-kind radioisotope platform to produce actinium-225 (Ac-225) and more than 25 isotopes for healthcare

• n.c.a. Lu-177: Available H1 2025 – Nusano has developed a proprietary isotope separation process to enable n.c.a. Lu-177 production on a scale far greater than existing methods. Our n.c.a. Lu-177 program is scheduled to begin H1 2025 to supply current and anticipated medical needs.
• Ac-225: Available 2026 – Nusano’s deuteron-beam production produces far more Ac-225 per gram of starting material than other methods.

Nusano is now accepting reservations for its full menu of radioisotopes. Contact us to request a custom quote and discuss your supply needs for 2025 and beyond.

Nusano Production Platform

Opening in 2025 in West Valley City, Utah, our production platform will support Ac-225 production and be capable of generating more than 25 radioisotopes for oncology and healthcare applications. It is anchored by a proprietary ion source which accelerates heavy particles (alphas and deuterons) to generate high volume, cGMP-grade radioisotopes with unparalleled efficiency using eco-friendly methods. The result is one of the first significant advancements in radioisotope production in decades. The flexibility of the Nusano production platform enables early-stage development and collaboration opportunities for radiopharmaceutical companies and researchers. Contact us to discuss not only high-volume production but also tailored solutions and learn how Nusano can support your product pipeline from clinical trials through commercial production.

In-House Capabilities & Expertise

Radioisotope Quality & Variety – Nusano’s proprietary production platform can produce more than 25 isotopes of interest to medicine, including up to 12 different kinds of isotopes simultaneously. View production capabilities: https://nusano.com/products/

Fast Shipping & White Glove Logistics – Our strategically chosen location – just 10 minutes from the FedEx hub at Salt Lake City International Airport– allows for timely, reliable delivery of radioisotopes to locations throughout the United States and the world.

Stable Isotope Enrichment Program – Enriched, stable isotopes are foundational material for radioisotope production. Nusano’s in-house program provides better control over source material and increased reliability for customers.

Radiochemistry – An expert team committed to ensuring the highest standards of isotopic purity and replicability for pharmaceutical development.

Contact Us

• Stacia Parker, Sr. Director of Sales, stacia.parker@nusano.com, (863) 221-5570
• sales@nusano.com
• Learn more at www.nusano.com